Sahil Chopra

Sahil Chopra is an Investment Associate at Vertex Ventures HC. Sahil completed his Ph.D. from Weill Cornell Graduate School (joint program at Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine) in New York. His thesis was focused on understanding the stress responses in immune cells within the tumor microenvironment. He worked in the lab of Dr. Laurie Glimcher (former dean of Weill Cornell and the current president and CEO of Dana Farber Cancer Institute, Harvard University) and Dr. Juan Cubillos-Ruiz, scientific co-founders of venture-backed Quentis Therapeutics. He successfully led and managed large scale scientific collaborations at major academic institutes including Harvard, UPenn, and Wake Forest University resulting in publications in high impact journals including Science, Nature and Cell with over 375 citations. He holds a patent on methods for non-opioid pain relief.

Sahil has prior experience in consulting for immunology based startups, banks (equity research) and mid-sized biotech firms. He was also a venture fellow at FundRx. He has won two international consulting competitions at Yale University and a startup business competition (VAbeachbio challenge). He successfully completed CFA level 1 in 2017. His interests lie in transformative medical technologies and therapies that impact patient lives.

Sahil was born and raised in India. He loves to play soccer and ping-pong. He also likes to travel, explore new places, cultures and try authentic cuisines.